Med-话题@MedSci

#Med#

6333篇内容 | 2716人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1611405, encodeId=737e1611405a8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=J. Clin. Med：依鲁替尼治疗 CLL 患者的长期疗效和安全性：真实生活体验。 , objectType=article, longId=293868, objectId=f6e9293868c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e9293868c5, replyNumber=0, likeNumber=120, createdTime=2022-01-13, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e9293868c5, moduleTitle=J. Clin. Med：依鲁替尼治疗 CLL 患者的长期疗效和安全性：真实生活体验。 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e9293868c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611403, encodeId=114216114036e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Ann Intern Med：接受肿瘤坏死因子抑制剂治疗的患者接种水痘-带状疱疹活疫苗的安全性和免疫学效果, objectType=article, longId=293604, objectId=1af629360491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1af629360491, replyNumber=0, likeNumber=72, createdTime=2022-01-09, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1af629360491, moduleTitle=Ann Intern Med：接受肿瘤坏死因子抑制剂治疗的患者接种水痘-带状疱疹活疫苗的安全性和免疫学效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1af629360491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611404, encodeId=f9b9161140438, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Nature Biomedical Engineering：靶向线粒体自噬，清除大脑“垃圾”，治疗阿尔茨海默病, objectType=article, longId=293595, objectId=b98a2935956b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b98a2935956b, replyNumber=0, likeNumber=15, createdTime=2022-01-09, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b98a2935956b, moduleTitle=Nature Biomedical Engineering：靶向线粒体自噬，清除大脑“垃圾”，治疗阿尔茨海默病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b98a2935956b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611402, encodeId=27921611402e7, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=J Clin Med：艾多沙班在韩国和中国台湾AF患者中的疗效分析, objectType=article, longId=293583, objectId=cda32935831e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda32935831e, replyNumber=0, likeNumber=71, createdTime=2022-01-09, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda32935831e, moduleTitle=J Clin Med：艾多沙班在韩国和中国台湾AF患者中的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cda32935831e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611401, encodeId=49dc161140144, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=J INTERN MED：巨细胞动脉炎和/或风湿性多肌痛患者的血栓栓塞风险如何？, objectType=article, longId=293499, objectId=6622293499ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6622293499ae, replyNumber=0, likeNumber=78, createdTime=2022-01-07, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6622293499ae, moduleTitle=J INTERN MED：巨细胞动脉炎和/或风湿性多肌痛患者的血栓栓塞风险如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6622293499ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611394, encodeId=c8ce161139486, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Nat Med展望 2022：后疫情时代，生物医学领域的研究趋势会有哪些？, objectType=article, longId=293467, objectId=21be29346e8a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21be29346e8a, replyNumber=0, likeNumber=59, createdTime=2022-01-07, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21be29346e8a, moduleTitle=Nat Med展望 2022：后疫情时代，生物医学领域的研究趋势会有哪些？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21be29346e8a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611398, encodeId=3deb161139834, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Nat Med：β-地中海贫血成人珠蛋白慢病毒基因治疗效果如何？, objectType=article, longId=293453, objectId=ffdd29345316, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffdd29345316, replyNumber=0, likeNumber=55, createdTime=2022-01-07, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffdd29345316, moduleTitle=Nat Med：β-地中海贫血成人珠蛋白慢病毒基因治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffdd29345316)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611397, encodeId=e36d161139ea4, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Phytomedicine：注射用益气复脉(冻干)通过抑制神经元自噬，减轻脑缺血损伤, objectType=article, longId=293439, objectId=3c7d2934391c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c7d2934391c, replyNumber=0, likeNumber=81, createdTime=2022-01-06, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c7d2934391c, moduleTitle=Phytomedicine：注射用益气复脉(冻干)通过抑制神经元自噬，减轻脑缺血损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c7d2934391c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611400, encodeId=a5af16114001e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Ther Adv Med Oncol：韩国大型真实世界数据评估雷莫芦单抗（Ramucirumab）联合紫杉醇作为二线治疗晚期胃或胃食管交界处腺癌患者的疗效(KCSG-ST19-16), objectType=article, longId=293431, objectId=ec882934312f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec882934312f, replyNumber=0, likeNumber=67, createdTime=2022-01-06, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec882934312f, moduleTitle=Ther Adv Med Oncol：韩国大型真实世界数据评估雷莫芦单抗（Ramucirumab）联合紫杉醇作为二线治疗晚期胃或胃食管交界处腺癌患者的疗效(KCSG-ST19-16), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec882934312f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611399, encodeId=63a216113998e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Ther Adv Med Oncol：Bendamustine (苯达莫司汀)联合卡培他滨治疗经治的HER2阴性乳腺癌患者的疗效, objectType=article, longId=293430, objectId=627129343025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=627129343025, replyNumber=0, likeNumber=75, createdTime=2022-01-06, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=627129343025, moduleTitle=Ther Adv Med Oncol：Bendamustine (苯达莫司汀)联合卡培他滨治疗经治的HER2阴性乳腺癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=627129343025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611395, encodeId=6d11161139570, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Ther Adv Med Oncol：揭示HER2+晚期乳腺癌患者20年治疗方式和临床预后（PANHER研究）, objectType=article, longId=293422, objectId=a555293422c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a555293422c3, replyNumber=0, likeNumber=62, createdTime=2022-01-06, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a555293422c3, moduleTitle=Ther Adv Med Oncol：揭示HER2+晚期乳腺癌患者20年治疗方式和临床预后（PANHER研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a555293422c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611396, encodeId=5752161139632, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=PLOS MED：不论心血管状况，不论运动强度，锻炼都能降低心血管死亡率！, objectType=article, longId=293421, objectId=c0672934218c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0672934218c, replyNumber=0, likeNumber=0, createdTime=2022-01-06, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0672934218c, moduleTitle=PLOS MED：不论心血管状况，不论运动强度，锻炼都能降低心血管死亡率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0672934218c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611392, encodeId=299a16113929b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Int J Nanomedicine：层状双氢氧化物可以促进口服胰岛素的高效吸收, objectType=article, longId=293277, objectId=a3962932e766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3962932e766, replyNumber=0, likeNumber=60, createdTime=2022-01-03, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3962932e766, moduleTitle=Int J Nanomedicine：层状双氢氧化物可以促进口服胰岛素的高效吸收, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3962932e766)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611390, encodeId=c9b51611390fb, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=N Engl J Med：度鲁特韦（Dolutegravir）作为儿童HIV-1感染的一线或二线治疗优于标准治疗, objectType=article, longId=293179, objectId=48b22931e963, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48b22931e963, replyNumber=0, likeNumber=72, createdTime=2022-01-01, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48b22931e963, moduleTitle=N Engl J Med：度鲁特韦（Dolutegravir）作为儿童HIV-1感染的一线或二线治疗优于标准治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48b22931e963)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611391, encodeId=8196161139199, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=N Engl J Med：第三针BNT162b2疫苗接种对Omicron中和效果如何, objectType=article, longId=293174, objectId=5ae82931e483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ae82931e483, replyNumber=0, likeNumber=0, createdTime=2022-01-01, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ae82931e483, moduleTitle=N Engl J Med：第三针BNT162b2疫苗接种对Omicron中和效果如何, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ae82931e483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611386, encodeId=bd3d1611386f7, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=JAMA Intern Med：患者生命体征实时预测工具用于识别病情稳定患者, objectType=article, longId=293116, objectId=a77c293116c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a77c293116c4, replyNumber=0, likeNumber=83, createdTime=2021-12-31, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a77c293116c4, moduleTitle=JAMA Intern Med：患者生命体征实时预测工具用于识别病情稳定患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a77c293116c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611389, encodeId=5812161138990, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Ther Adv Med Oncol：在FOLFIRINOX治疗失败的晚期胰腺癌患者中，GnP（吉西他滨+白蛋白结合型紫杉醇）是可行的治疗措施, objectType=article, longId=293056, objectId=308a29305649, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=308a29305649, replyNumber=0, likeNumber=0, createdTime=2021-12-30, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=308a29305649, moduleTitle=Ther Adv Med Oncol：在FOLFIRINOX治疗失败的晚期胰腺癌患者中，GnP（吉西他滨+白蛋白结合型紫杉醇）是可行的治疗措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=308a29305649)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611385, encodeId=18241611385af, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=Ther Adv Med Oncol：中肿石明教授团队回顾性研究发现仑伐替尼+特瑞普利单抗+肝动脉灌注化疗（HAIC）可改善晚期肝细胞癌患者预后, objectType=article, longId=293055, objectId=28ee293055ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ee293055ec, replyNumber=0, likeNumber=84, createdTime=2021-12-30, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ee293055ec, moduleTitle=Ther Adv Med Oncol：中肿石明教授团队回顾性研究发现仑伐替尼+特瑞普利单抗+肝动脉灌注化疗（HAIC）可改善晚期肝细胞癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28ee293055ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611383, encodeId=c7891611383fd, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=JAMA Intern Med：孕期生活方式干预对妊娠期间体重过度增加及围产期不良结局风险的影响, objectType=article, longId=293054, objectId=0efa2930546b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0efa2930546b, replyNumber=0, likeNumber=80, createdTime=2021-12-30, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0efa2930546b, moduleTitle=JAMA Intern Med：孕期生活方式干预对妊娠期间体重过度增加及围产期不良结局风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0efa2930546b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1611382, encodeId=8afe16113827d, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, objectTitle=BMC Med：肥胖的代谢特征与结直肠癌和子宫内膜癌相关，减肥后可逆转！, objectType=article, longId=293040, objectId=35e1293040ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35e1293040ef, replyNumber=0, likeNumber=77, createdTime=2021-12-30, rootId=0, userName=ms3994565386320060, userId=552a19396740, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35e1293040ef, moduleTitle=BMC Med：肥胖的代谢特征与结直肠癌和子宫内膜癌相关，减肥后可逆转！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35e1293040ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Med

2020-05-29

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

J. Clin. Med：依鲁替尼治疗 CLL 患者的长期疗效和安全性：真实生活体验。

2022-01-13

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Ann Intern Med：接受肿瘤坏死因子抑制剂治疗的患者接种水痘-带状疱疹活疫苗的安全性和免疫学效果

2022-01-09

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Nature Biomedical Engineering：靶向线粒体自噬，清除大脑“垃圾”，治疗阿尔茨海默病

2022-01-09

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

J Clin Med：艾多沙班在韩国和中国台湾AF患者中的疗效分析

2022-01-09

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

J INTERN MED：巨细胞动脉炎和/或风湿性多肌痛患者的血栓栓塞风险如何？

2022-01-07

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Nat Med展望 2022：后疫情时代，生物医学领域的研究趋势会有哪些？

2022-01-07

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Nat Med：β-地中海贫血成人珠蛋白慢病毒基因治疗效果如何？

2022-01-07

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Phytomedicine：注射用益气复脉(冻干)通过抑制神经元自噬，减轻脑缺血损伤

2022-01-06

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Ther Adv Med Oncol：韩国大型真实世界数据评估雷莫芦单抗（Ramucirumab）联合紫杉醇作为二线治疗晚期胃或胃食管交界处腺癌患者的疗效(KCSG-ST19-16)

2022-01-06

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Ther Adv Med Oncol：Bendamustine (苯达莫司汀)联合卡培他滨治疗经治的HER2阴性乳腺癌患者的疗效

2022-01-06

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Ther Adv Med Oncol：揭示HER2+晚期乳腺癌患者20年治疗方式和临床预后（PANHER研究）

2022-01-06

智者为医08 (审核中...)

前往app查看评论内容

#Med#

PLOS MED：不论心血管状况，不论运动强度，锻炼都能降低心血管死亡率！

2022-01-06

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Int J Nanomedicine：层状双氢氧化物可以促进口服胰岛素的高效吸收

2022-01-03

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

N Engl J Med：度鲁特韦（Dolutegravir）作为儿童HIV-1感染的一线或二线治疗优于标准治疗

2022-01-01

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

N Engl J Med：第三针BNT162b2疫苗接种对Omicron中和效果如何

2022-01-01

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

JAMA Intern Med：患者生命体征实时预测工具用于识别病情稳定患者

2021-12-31

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Ther Adv Med Oncol：在FOLFIRINOX治疗失败的晚期胰腺癌患者中，GnP（吉西他滨+白蛋白结合型紫杉醇）是可行的治疗措施

2021-12-30

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

Ther Adv Med Oncol：中肿石明教授团队回顾性研究发现仑伐替尼+特瑞普利单抗+肝动脉灌注化疗（HAIC）可改善晚期肝细胞癌患者预后

2021-12-30

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

JAMA Intern Med：孕期生活方式干预对妊娠期间体重过度增加及围产期不良结局风险的影响

2021-12-30

ms3994565386320060 (审核中...)

前往app查看评论内容

#Med#

BMC Med：肥胖的代谢特征与结直肠癌和子宫内膜癌相关，减肥后可逆转！

2021-12-30

科室
- - 订阅+
  - 更多科室
工具
服务